
UNC Pancreas Center
@uncpancreas
Official Twitter account for the UNC Lineberger Pancreatic Cancer Center of Excellence #uncpancreas
ID: 1478773803446587405
https://unclineberger.org/pancreatic-cancer-center-of-excellence 05-01-2022 17:04:12
165 Tweet
299 Followers
128 Following

We're pleased to announce Sarah Shelton has earned our 2024-25 National Cancer Institute SPORE CEP Award for her project, "Developing Microphysiological Systems to Unravel the Complex Tumor Microenvironment in Pancreatic Cancer." Congratulations, Dr. Shelton, can't wait to watch your progress!


If you are the first or corresponding author of a 2023 or 2024 Cancer Discovery paper, Assistant Professor or equivalent, and have received your PhD/MD in the past 12 years - apply! The deadline is January 10!


Investigators from 13 #GICancer SPOREs joined us UNC Lineberger this month to share findings from their SPORE-supported research. Thanks to National Cancer Institute for helping us bring together so many brilliant minds to collaborate in one room. Together we progress! go.unc.edu/Dw2z8


Our PANcreatic adenocarcinoma with Gemcitabine, Erlotinib, and nAb-paclitaxel (PANGEA) trial is now recruiting #pancreaticcancer patients to test this combination treatment in advanced unresectable or metastatic basal-like subtype PDAC National Cancer Institute Cancer Discovery go.unc.edu/Aa37Y

Beautiful day for #PurpleStride. So proud of UNC's Running RAScals and our recording breaking year. UNC Lineberger Pylayeva-Gupta lab UNC Pancreas Center Der Lab at UNC




The UNC running RAScals showed up strong at the PanCAN Purple Stride, raising more than $25,000 for pancreatic cancer research and support! 💜 Thank you to everyone who walked, donated, and made an impact. Raleigh-Durham - Pancreatic Cancer Action Network UNC Pancreas Center Der Lab at UNC Pylayeva-Gupta lab Bryant Lab UNC




At #AACR25 this afternoon, Madison Jenner will present during the poster session: (Poster 24) Patient-derived cell line and organoid drug screening identifies synergistic PLK1 inhibitor in combination with senolytic ABT-263 for pancreatic cancer. UNC Pancreas Center ⌚️: 2 – 5 p.m. CT



UNC Lineberger researchers and colleagues have discovered an important overlap in genes regulated by the activity of three proteins that support the growth of pancreatic cancer. #UnitedByCancerResearch #NCRM25 UNC Pancreas Center unclineberger.org/news/new-drug-…

🎉 Congrats to our outstanding UNC School of Medicine Conquer Cancer, the ASCO Foundation awardees 🏅 Dr. Chemtai Mungo,MD,MPH – Career Development Award 🏅 Dr. Yash Agrawal – Young Investigator Award (YIA) 🏅 Dr. Jaewon J. Lee – YIA We’re proud to see your impactful research honored on the national stage! UNC Lineberger

Check out some highlights from the innovative #pancreaticcancer projects funded by the UNC Lineberger Developmental Research Program in the first two years of our National Cancer Institute SToP Cancer SPORE grant 🔬📔 go.unc.edu/f5DCp

“After going through the process of treatment with him and realizing how few options there were for pancreatic cancer patients … I felt like I was in a position to potentially make a difference with the training that I had" UNC Lineberger's Kirsten Bryant (Bryant Lab UNC), PhD,
